Sucralfate Tablet
Product Images NDC 70771-1833

2 FDA label images from Zydus Lifesciences Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Sucralfate (NDC 70771-1833). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (F0b6479d 234b 426c 8035 6e4675d8853a 01)

Figure (F0b6479d 234b 426c 8035 6e4675d8853a 01)
Chemical structure of sucralfate showing its polymeric arrangement with aluminum hydroxide and hydration components, illustrating the molecular composition as represented by the formula including aluminum hydroxide groups and water molecules.*
FDA Label Image

Image (F0b6479d 234b 426c 8035 6e4675d8853a 02)

Image (F0b6479d 234b 426c 8035 6e4675d8853a 02)
Label for Sucralfate Tablets, USP 1 gram oral dosage form by Zydus Lifesciences Limited. The label indicates a package of 30 uncoated tablets with prescription use only. It includes storage instructions, warnings, and pharmacy handling requirements, with the NDC 70771-1833-3 prominently displayed.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.